Search

Although there are many different types of news on our website, in a certain respect they are all the same. The news has something to do with the work of our institute and the people who work here. That is the case now. Emil Koplányi, a student of Imre Kalló, was among the high school students who were welcomed at the Sándor Palace. What's more, Emil was one of the three students who were able to present their work.

The internet has finally taken over the SfN conferences, and there is hardly anyone who doesn't have a smartphone/iPad in their hand at all times. Excellent apps help you to find your way quickly and easily, which is a must at a conference with more than 22,000 participants. But the technical innovation only shows that the conference is moving with the times. The essence today is still what its creators envisioned in 1971: neuroscience from A to Z.

Tetrabenazine, a VMAT-2 enzyme inhibitor, is used to treat sudden movements caused by neurodegenerative diseases called Huntington's disease and tardive dyskinesia, which are uncontrollable by the individual. The extent to which this drug inhibits the release of the monoamines noradrenaline, dopamine, and serotonin in different brain areas is not yet known. This is what a collaboration between the Sperlágh group and researchers at Richter Gedeon Nyrt led by Szilveszter E. Vizi investigated. The significance of the result is underlined by the fact that the work, first submitted by Pál Tod and with corresponding authorship by Professor Vizi, was published in the leading international journal of pharmacology.    

"Autumn is here, it's here again", we could have said with Petőfi, and we could have agreed with the rest, that autumn is beautiful. The first day of our stay in Várgestes, 26 September, was so beautiful that you couldn't wish for a more beautiful day since the end of September. The main reason for our satisfaction, however, was that our Institute conference went very well!

The HUN-REN KOKI and the Weizmann Institute in Israel co-organised a two-day symposium at the KOKI, 28-29 October 2024, which contributed to the promotion of long-term joint neuroscience research between Hungary and Israel.        

Program: Human Neuropixels recordings in the operation room - Domonkos Meszéna at the KOKI Lecture Hall, 2024.10.24. (Thursday) 18:00   After the the presentation we will have a social program at the GrundHosts: Anna Bakacsi, Boldizsar Balog, Boglarka Toth

Copenhagen not only provided an excellent venue, but also a wonderful summer weather during the last week of August for the 2500 participants of EMC204, the largest meeting of microscopists in Europe. The Hungarian Microscopy Society was represented by Techoorg Linda and eight microscopists, including four colleagues from KOKI.

Our institute is known as a brain research institute, one of the excellence in basic neuroscience research at home and abroad, so it is legitimate to ask where this special title comes from. Hair grows outside the skull, our brains nest inside the skull. Or can the cat in János Arany's ballad catch mice inside and out?

KOKI is special in many ways, and another fact confirms this. Our Institute now has HUN-REN ARP Ambassadors.

The Molecular Cell Metabolism Research Group led by Dr. Balázs Gereben and the Integrative Neuroendocrinology Research Group led by Dr. Csaba Fekete developed a new approach that may contribute to better healthcare for many patients with thyroid hormone (TH) related disorders. The preliminary results of the paper were presented by the first author, Richárd Sinkó, at the Annual Meeting of the European Thyroid Association (ETA) 2023, where the work was awarded the Society's Berlin-Chemie Menarini Young Investigators' Award. The results, obtained in collaboration with the research group of Dr. Endre Nagy from the University of Debrecen and several Hungarian clinical endocrine centers have been published in the Journal of Clinical Endocrinology and Metabolism.